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Abstract
Rationale: In many organs, hypoxic cell death triggers sterile
neutrophilic inflammation via IL-1R signaling. Although
hypoxia is common in airways from patients with cystic fibrosis
(CF), its role in neutrophilic inflammation remains unknown.
We recently demonstrated that hypoxic epithelial necrosis
caused by airway mucus obstruction precedes neutrophilic
inflammation in Scnn1b-transgenic (Scnn1b-Tg) mice with
CF-like lung disease.
Objectives: To determine the role of epithelial necrosis and IL-1R
signaling in the development of neutrophilic airway inflammation,
mucus obstruction, and structural lung damage in CF lung disease.
Methods:Weused genetic deletion and pharmacologic inhibition of
IL-1R in Scnn1b-Tgmice and determined effects on airway epithelial
necrosis; levels of IL-1a, keratinocyte chemoattractant, and neutrophils
in bronchoalveolar lavage; and mortality, mucus obstruction, and
structural lung damage. Furthermore, we analyzed lung tissues from
21 patients with CF and chronic obstructive pulmonary disease and
19 control subjects for the presence of epithelial necrosis.
Measurements and Main Results: Lack of IL-1R had no effect on
epithelialnecrosis andelevated IL-1a, but abrogatedairwayneutrophilia
and reduced mortality, mucus obstruction, and emphysema in
Scnn1b-Tg mice. Treatment of adult Scnn1b-Tg mice with the IL-1R
antagonist anakinrahadprotective effects onneutrophilic inflammation
and emphysema. Numbers of necrotic airway epithelial cells were
elevated and correlatedwithmucus obstruction in patients with CF and
chronic obstructive pulmonary disease.
Conclusions: Our results support an important role of hypoxic
epithelial necrosis in the pathogenesis of neutrophilic inflammation
independent of bacterial infection and suggest IL-1R as a novel
target for antiinflammatory therapy in CF and potentially other
mucoobstructive airway diseases.
Keywords: airway inflammation; airway epithelium; mucus
obstruction; cystic fibrosis; chronic obstructive pulmonary disease
Recent studies in infants with cystic fibrosis
(CF) diagnosed by newborn screening
identified neutrophilic inflammation and air
trapping caused by small airways mucus
obstruction as early abnormalities that are
present in most infants often in the absence
of detectable bacterial infection and
respiratory symptoms (1, 2). Neutrophilic
inflammation has been implicated in
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several disease processes in CF lung
disease including dysregulated epithelial ion
transport and structural lung damage,
and neutrophil elastase (NE), a major
neutrophil product, was identified as a key
risk factor for bronchiectasis and lung
function decline in children with CF (3–9).
Furthermore, evidence suggests that
mediators released in neutrophilic airway
inflammation contribute to goblet cell
metaplasia and mucus hypersecretion
under certain, but not all pathophysiologic
conditions (9–11). However, the in vivo
pathogenesis of neutrophilic inflammation
in the absence of apparent bacterial
infection in early CF lung disease remains
unknown.
Besides bacterial infection, cell injury
and necrosis constitutes another principal
stimulus of inflammation. Evidence from
common diseases caused by tissue hypoxia,
such as myocardial infarction and ischemic
stroke, demonstrated that hypoxic cell
death provides a potent trigger of sterile
neutrophilic inflammation (12, 13).
Whereas inflammation in infection is
stimulated by binding of microbial
components to diverse Toll-like receptors
(TLR) that signal through the common
adaptor protein myeloid differentiation
primary response gene 88 (MyD88) (14),
recent studies in mouse models of sterile
peritonitis and liver necrosis identified
activation of IL-1R as a key pathway linking
necrosis with inflammation in the absence
of infection (12, 15). IL-1R is a cytokine
receptor that also uses MyD88 signaling
and is activated by IL-1a induced by dying
cells. Although reduced oxygen tension
caused by airway mucus plugging and
increased epithelial oxygen consumption
caused by increased absorption of
airways surface liquid is a characteristic
abnormality of CF airways (16, 17), the role
of hypoxic necrosis and IL-1R–MyD88
signaling in CF airways inflammation has
not been studied.
In previous studies using Scnn1b-Tg
mice as a model of CF lung disease (18, 19),
we demonstrated that airway surface
dehydration, a key disease mechanism in
CF, causes airway mucus obstruction in the
first days of life, that early mucus plugging
is associated with systemic and cellular
hypoxia of airway epithelia, and that
a subset of Clara cell undergoes hydropic
degeneration and necrosis (20).
Furthermore, we observed that the
appearance of necrotic cells preceded the
onset of airway neutrophilia in neonatal
Scnn1b-Tg mice (20). The abundance of
necrotic epithelial cells correlated with the
severity of airway mucus obstruction (21)
and was decreased when mucus plugging
was reduced by preventive amiloride
treatment in neonatal Scnn1b-Tg mice (22).
The aim of this study was, therefore,
to determine the role of airway epithelial
necrosis and IL-1R–MyD88 pathway
activation in the in vivo pathogenesis of
neutrophilic inflammation associated with
mucus obstruction. To achieve this goal,
we crossed Scnn1b-Tg mice with
IL-1R–deficient mice (Il1r12/2) and
determined effects of genetic deletion of
Il1r on airway epithelial necrosis, IL-1a
levels, airway neutrophilia, mucus
obstruction, structural lung damage, and
mortality. Furthermore, we used the IL-1R
antagonist (IL-1Ra) anakinra (15) to
determine effects of pharmacologic
inhibition of IL-1R signaling in adult
Scnn1b-Tg mice with established lung
disease. In addition, we compared
expression profiles of genes implicated
in airway inflammation in lungs from
neonatal Scnn1b-Tg mice with mild versus
severe mucus plugging using whole-
genome microarray analysis. Finally,
we used in situ hybridization and
immunohistochemistry to localize IL-1a
expression in mouse lungs, and evaluated
airways sections from patients with CF and
chronic obstructive pulmonary disease
(COPD) for the presence of necrotic
epithelial cells. Some of the results of these
studies have been previously reported in
the form of an abstract (23).
Methods
Human Lung Tissues
Lung tissues from 13 patients with CF
(29.26 1.9 yr) who underwent lung
transplantation and eight patients with
COPD (66.66 3.3 yr) diagnosed according
to Global Initiative for Chronic Obstructive
Lung Disease guidelines (24) were included
in this study. Lung tissues from 16 never
smokers (68.66 2.4 yr) with normal lung
function who underwent surgical resection
for suspected lung cancer and from three
donors with no lung disease (15.36 5.5 yr)
were included as control subjects. This
study was approved by the ethics
committees of the University of Heidelberg
and the Hannover Medical School, and
the institutional review board of the
University of North Carolina at Chapel
Hill. Informed written consent was obtained
from all subjects. Additional information is
provided in the online supplement.
Experimental Animals
All animal studies were approved by the
Regierungspräsidium Karlsruhe, Germany.
Scnn1b-Tg mice (18) were backcrossed
onto the C57BL/6 background (21) and
intercrossed with Il1r12/2 mice on
the C57BL/6 background (Jackson
Laboratory, Bar Harbor, ME) (25) to
At a Glance Commentary
Scientific Knowledge on the
Subject: Recent studies in infants
with cystic fibrosis (CF) detected
neutrophilic inflammation and small
airways mucus obstruction as early
abnormalities that are often present
in the apparent absence of bacterial
infection. IL-1a derived from necrotic
cells has been identified as a potent
trigger of sterile neutrophilic
inflammation. Although mucus-
obstructed CF airways exhibit areas of
hypoxia (i.e., a common cause of
necrotic cell death), the role of hypoxic
epithelial necrosis, IL-1a, and IL-1R
signaling in CF airway inflammation
remains unknown.
What This Study Adds to the
Field: This study identifies hypoxic
epithelial necrosis with release of IL-1a
and activation of IL-1R–myeloid
differentiation primary response gene
88 signaling as a potent trigger of
neutrophilic airway inflammation
in mice with CF-like lung disease.
Furthermore, we demonstrate an
increased abundance of necrotic
epithelial cells in mucus-obstructed
airways from patients with CF and
chronic obstructive pulmonary
disease. These results support an
important role of hypoxic epithelial
necrosis in the in vivo pathogenesis
of neutrophilic inflammation
independent of bacterial infection and
suggest IL-1R as a novel target for
antiinflammatory therapy in patients
with CF and potentially other
mucoobstructive lung diseases.
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generate Scnn1b-Tg/Il1r12/2, Scnn1b-Tg,
Il1r12/2, and wild-type (WT) mice in the
second filial generation. Offspring were
genotyped as described (18, 25) and mice
were studied at neonatal (5 d) or adult
(6 wk) ages. Microarray analyses were
performed in neonatal (3 d old) and
anakinra treatment studies in adult (4–6 wk
old) Scnn1b-Tg mice and WT littermate
control animals on the original mixed
genetic background (C57BL/6N3 C3H/
HeN) (18, 20). Mice were housed in
a specific pathogen-free animal facility and
had free access to chow and water.
Anakinra Treatment
Adult (4–6 wk old) Scnn1b-Tg mice and
WT littermates were treated with the IL-
1Ra anakinra (Kineret; Swedish Orphan
Biovitrum AB, Stockholm, Sweden) (15) by
subcutaneous injection of 200 mg/kg body
weight, or equal volumes of vehicle (NaCl
0.9%) alone, twice per day for a period of 7
days. Twelve hours after the last treatment,
bronchoalveolar lavage (BAL) was performed
and lungs were removed for further analysis
as described in the online supplement.
BAL Cell Counts and Cytokine
Measurements
Mice were anesthetized via intraperitoneal
injection of 120 mg/kg ketamine and
16 mg/kg xylazine. BAL, differential cell
counts, and ELISA of cytokines were
performed as previously described (20).
Additional details are provided in the
online supplement.
Histology and Morphometry
Degenerative airway epithelial cells were
identified by morphologic criteria (i.e., cell
swelling with cytoplasmic vacuolization)
and quantified by counting the number of
degenerative cells per millimeter of the
basement membrane. Histologic and
morphometric analyses of airway mucus
content and assessment of distal airspace
enlargement and alveolar wall destruction
were performed as previously described
(20, 26, 27) and detailed in the online
supplement.
Immunohistochemistry
Immunohistochemical staining for IL-1a
was performed using a goat polyclonal
antimouse–IL-1a antibody (R&D Systems,
Minneapolis, MN) as previously described
(28) and detailed in the online supplement.
RNA In Situ Hybridization
Nonradioactive in situ hybridization of
IL-1a transcripts was performed on 10-mm
sections of paraffin-embedded lung
tissues using custom designed 59 and 39
DIG-labeled IL-1a antisense and
sense locked nucleic acid–modified
oligonucleotide probes (Exiqon, Woburn,
MA) as previously described (29) and
detailed in the online supplement.
Microarray Analysis
Microarray analysis was performed using
Mouse Genome 430 2.0 Microarrays
(Affymetrix, Santa Clara, CA) and
quantitative real-time reverse transcriptase
polymerase chain reaction was performed
for confirmation of candidate genes as
described in the online supplement.
Statistics
Data were analyzed with SigmaStat version
3.1 (Systat Software, Erkrath, Germany) and
are reported as mean 6 SEM. Statistical
analyses were performed using Student
t test, Mann-Whitney rank sum test, one-
way analysis of variance, chi-square test,
and Pearson product-moment correlation
as appropriate and P less than 0.05 was
accepted to indicate statistical significance.
Results
Lack of IL-1R Reduces Neutrophilic
Airway Inflammation Associated with
Epithelial Necrosis in Scnn1b-Tg Mice
To determine if IL-1R is implicated in the
onset of neutrophilic airway inflammation
associated with airway epithelial necrosis
in early lung disease in Scnn1b-Tg mice
(20), we compared numeric densities of
degenerative airway epithelial cells, BAL
inflammatory cell counts, macrophage size,
and levels of the keratinocyte chemoattractant
(KC), IL-1a, IL-1b, and IL-1Ra in 5-day-old
neonatal Scnn1b-Tg/Il1r12/2 mice with
Scnn1b-Tg, Il1r12/2 and WT littermates
(Figure 1). Degenerative airway epithelial cells
were rarely observed in WT and Il1r12/2
mice, but were significantly increased in
Scnn1b-Tg mice (Figures 1A and 1B).
Epithelial necrosis in neonatal Scnn1b-Tg
mice was associated with an increase in
macrophages and neutrophils, increased
macrophage size (Figure 1C), and elevated
levels of KC, IL-1a, IL-1b, and IL-1Ra in
BAL (Figure 1D). Lack of IL-1R had no effect
on increased levels of degenerative epithelial
cells, BAL macrophages, and IL-1a, but
airway neutrophilia was abrogated and KC,
IL-1b, and IL-1Ra were significantly reduced
in Scnn1b-Tg/Il1r12/2 mice compared with
Scnn1b-Tg littermates.
To localize IL-1a mRNA and protein
expression in lungs of neonatal WT and
Scnn1b-Tg mice, we performed in situ
hybridization and immunohistochemistry
(Figure 2). With both techniques, we
obtained distinct IL-1a signals in the
epithelium lining the conducting airways
and to a lesser extent in lung parenchyma
of WT and Scnn1b-Tg mice (Figure 2).
Consistent with the translocation of
IL-1a protein to the nucleus (13),
immunoreactive signals were clearly
detected in the cytoplasm and nucleus of
epithelial cells, whereas only faint staining
was observed in macrophages sporadically
detected in lung sections from WT and
Scnn1b-Tg mice (Figure 2B; see Figure E1
in the online supplement). Taken together,
these results show constitutive expression
of IL-1a by the airway epithelium and lung
parenchyma, and suggest that epithelial
cells undergoing necrosis constitute a major
source of increased IL-1a levels in neonatal
Scnn1b-Tg mice.
In 6-week-old adult Scnn1b-Tg mice,
absolute numbers of degenerative airway
epithelial cells were lower than at neonatal
ages, but remained elevated compared
with WT control animals (Figure 3A).
Similar to the results obtained in the
neonatal studies, lack of IL-1R had no
effects on the level of degenerative airway
cells (Figure 3A), but neutrophils and KC
were significantly reduced in BAL from
Scnn1b-Tg/Il1r12/2 mice compared with
Scnn1b-Tg mice (Figures 3B and 3C).
Collectively, these results demonstrate that
IL-1R signaling plays an important role in
the initiation and perpetuation of airway
neutrophilia and suggest that necrotic cell
death and release of IL-1a in mucus-
obstructed hypoxic airways contribute to
IL-1R–dependent neutrophilic airway
inflammation in Scnn1b-Tg mice.
Lack of IL-1R Reduces Airway
Mucus Obstruction and Mortality in
Scnn1b-Tg Mice
Because chronic neutrophilic inflammation
is associated with airway mucus plugging,
we determined effects of genetic deletion of
IL-1R on mucus obstruction and related
mortality in Scnn1b-Tg mice (20).
Consistent with spontaneous postnatal
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mortality observed in previous studies (18,
20), the percentage of surviving Scnn1b-Tg
mice was significantly lower than the
expected mendelian ratio for the intercross
of Scnn1b-Tg with Il1r12/2 mice, whereas
Scnn1b-Tg/Il1r12/2 mice were protected
from postnatal mortality (Figure 4A).
Morphometric analysis of airway sections
from 6-week-old adult mice demonstrated
that airway mucus obstruction in Scnn1b-
Tg mice was significantly reduced in
Scnn1b-Tg/Il1r12/2 mice (Figures 4B and
4C). The notion that IL-1R signaling is
implicated in airway mucus obstruction
was supported by independent studies
using whole-genome cDNA microarray
analysis of lungs from neonatal Scnn1b-Tg
mice on a mixed genetic background
(C57BL/6N3 C3H/HeN) that develop
more heterogeneous disease (18, 20) and
were selected for exhibiting either mild
(<20% of luminal area) or severe (>80% of
luminal area) tracheal mucus obstruction
(Figures 5A and 5B).
Seeking for genes that were differentially
expressed in Scnn1b-Tg mice with mild
versus severe mucus plugging, with a focus
on genes implicated in inflammation using
custom gene set and gene set enrichment
analysis, we found that Il1ra was
differentially up-regulated in Scnn1b-Tg
mice with mild mucus obstruction
(Figure 5D). Significant up-regulation of
Il1ra (approximately threefold) in lungs
from Scnn1b-Tg mice with mild versus
severe airway obstruction was confirmed by
real-time reverse transcriptase polymerase
chain reaction (Figure 5E). Of note, the
number of necrotic airway cells did not
differ in Scnn1b-Tg mice with mild versus
severe tracheal obstruction indicating that


















































































































Figure 1. Lack of IL-1R reduces neutrophilic airway inflammation associated with epithelial necrosis in neonatal Scnn1b-Tg mice. Comparison of airway
epithelial necrosis (A and B), bronchoalveolar lavage (BAL) inflammatory cell counts and macrophage size (C) and keratinocyte chemoattractant (KC), IL-
1a, IL-1b, and IL-1Ra concentrations (D) in 5-day-old wild-type (WT), Il1r12/2, Scnn1b-Tg, and Scnn1b-Tg/ Il1r12/2 mice. (A) Representative airway
sections were stained with hematoxylin and eosin to determine the number of degenerative epithelial cells (arrows). Scale bars = 20 mm (top) and 10 mm
(bottom). (B) Summary of degenerative epithelial cells per millimeter of the basement membrane. n = 5–10 mice per group from 16 litters. *P, 0.01 and
**P< 0.001 compared with WT mice. (C) BAL cell counts and macrophage size. n = 8–18 mice per group from 22 litters. *P, 0.01 and **P< 0.001
compared with WT mice. †P, 0.05 and ‡P< 0.001 compared with Scnn1b-Tg mice. (D) KC, IL-1a, IL-1b, and IL-1Ra concentration in BAL. n = 4–10
mice per group from 15–20 litters. *P, 0.05 and **P< 0.001 compared with WT mice. †P, 0.05 and ‡P, 0.01 compared with Scnn1b-Tg mice. Eos. =
eosinophils; Lymph. = lymphocytes; Mac. = macrophages; PMN = neutrophils.
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necrotic cell death, modulated early mucus
obstruction in neonatal Scnn1b-Tg mice
(Figure 5C). Collectively, these results
demonstrate that IL-1R signaling is
implicated in airway mucus obstruction and
associated mortality in Scnn1b-Tg mice, and
suggest IL-1Ra as a potential modifier of
mucus plugging.
Lack of IL-1R Reduces Emphysema in
Scnn1b-Tg Mice
Chronic neutrophilic inflammation is
associated with emphysema in Scnn1b-Tg
mice (20, 30). To determine if IL-1R
signaling is implicated in the in vivo
pathogenesis of emphysema, we compared
mean linear intercepts as a measure of
distal airspace enlargement and destructive
index as a measure of alveolar wall
destruction in 6-week-old Scnn1b-Tg/
Il1r12/2 mice with Scnn1b-Tg, Il1r12/2
and WT littermates. As expected from
previous studies, mean linear intercepts
and destructive index were significantly
increased in Scnn1b-Tg mice compared
with WT (Figure 6). In Scnn1b-Tg/Il1r12/2
mice, emphysema parameters were
significantly reduced compared with
Scnn1b-Tg mice (Figure 6B). These results
suggest an important role of IL-1R
signaling in structural lung damage
characteristic of chronic lung disease in
Scnn1b-Tg mice.
Pharmacologic Inhibition of IL-1R
Signaling Reduces Neutrophilic
Airway Inflammation and Emphysema
in Adult Scnn1b-Tg Mice
To determine effects of pharmacologic
inhibition of IL-1R signaling, we treated
adult (4–6 wk old) Scnn1b-Tg mice and WT
littermates by subcutaneous injections of
the IL-1Ra anakinra for a period of 7 days.
Similar to genetic deletion of IL-1R,
treatment with anakinra had no effects on
epithelial necrosis, but abrogated airway
neutrophilia almost completely and
reduced KC levels in BAL significantly in
Scnn1b-Tg mice (Figures 7A–7C).
WT sense







Figure 2. Localization of IL-1a in lungs from neonatal wild-type (WT) and Scnn1b-Tg mice. (A) In situ
hybridization of lung sections from neonatal (5 d old) WT and Scnn1b-Tg mice with locked nucleic acid–
modified sense and antisense IL-1a mRNA detection probes. Representative localization of IL-1a
transcripts (dark blue) in airway and lung parenchymal cells in WT and Scnn1b-Tg lungs hybridized with
antisense probe. Staining was not detected in lung sections hybridized with sense probes. Scale
bars = 100 mm (top) and 10 mm (bottom). (B) Immunohistochemical detection of IL-1a in lung sections
from neonatal WT and Scnn1b-Tg mice. Representative localization of IL-1a (brown) in cytoplasm
and nuclei of airway epithelial cells and some parenchymal cells in WT and Scnn1b-Tg lungs stained
with primary anti–IL-1a antibody (IL-1a). Staining was not detected in lung sections incubated with
secondary antibody only (control). All sections were counterstained with hematoxylin. Scale bars =





















































Figure 3. Lack of IL-1R reduces neutrophilic airway inflammation in adult Scnn1b-Tg mice. Comparison of airway epithelial necrosis (A), bronchoalveolar
lavage (BAL) inflammatory cell counts (B), and keratinocyte chemoattractant (KC) levels (C) in 6-week-old wild-type (WT), Il1r12/2, Scnn1b-Tg, and
Scnn1b-Tg/Il1r12/2 mice. (A) Summary of degenerative epithelial cells per millimeter of basement membrane. n = 5–6 mice per group from 14 litters.
*P, 0.05 compared with WT mice. (B and C) Inflammatory cell counts (B) and concentration of KC (C) in BAL. n = 4–13 mice per group from 11–15 litters.
*P, 0.01 and **P< 0.001 compared with WT mice. †P, 0.01 and ‡P< 0.001 compared with Scnn1b-Tg mice. Eos. = eosinophils; Lymph. =
lymphocytes; Mac. = macrophages; PMN = neutrophils.
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Furthermore, anakinra treatment reduced
emphysema, as determined from
measurements of mean linear intercepts
and the destructive index (Figures 7D and
7E; see Figure E2). In addition, we observed
a trend toward reduction of airway mucus
obstruction (z40%; P = 0.058) in anakinra-
treated versus vehicle-treated Scnn1b-Tg
mice (Figure 7F). These results demonstrate
that pharmacologic inhibition of
IL-1R signaling reduces neutrophilic
inflammation and associated structural
lung damage in adult Scnn1b-Tg mice with
chronic lung disease.
Epithelial Degeneration Is Present in
Mucus-obstructed Airways of
Patients with CF and COPD
Our studies in mice with CF-like lung
disease indicate that epithelial necrosis in
mucus-obstructed airways may play an
important role in the in vivo pathogenesis of
neutrophilic inflammation. However, the
occurrence of necrotic epithelial cells in
airways from patients with CF and other
chronic obstructive lung diseases remains
unknown. We therefore evaluated sections
of small airways (,2 mm diameter)
from patients with CF or COPD and
nonsmoking control subjects for the
presence of degenerative epithelial cells
(Figures 8A and 8C) and airway mucus
(Figures 8A and 8B). Hydropic, highly
vacuolated degenerative epithelial cells
similar to the cells observed in Scnn1b-Tg
mice (Figure 1A) were rarely observed in
control subjects, but were significantly
increased in mucus-obstructed airways
from patients with CF (Figures 8A and 8C).
Similarly, numeric densities of degenerative
cells were increased in COPD compared
with control subjects (Figures 8A and 8C).
Of note, the number of necrotic airway
epithelial cells was significantly correlated
(r = 0.53; P, 0.01) with the severity of
airway mucus obstruction (Figure 8D).
These results provide initial evidence that
epithelial necrosis may be implicated in the
pathogenesis of CF and potentially other
chronic obstructive lung diseases in
humans.
Discussion
Neutrophilic airway inflammation plays
a key role in the onset and progression
of lung disease in CF and other chronic
obstructive lung diseases, even in the
apparent absence of bacterial infection
(1, 4, 5, 9, 31–33). However, stimuli other
than infection that can trigger airway
neutrophilia remain poorly understood
and therapeutic benefits of current
antiinflammatory and antiinfective
therapies remain limited. The importance
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Figure 4. Lack of IL-1R reduces mortality and airway mucus obstruction in Scnn1b-Tg mice.
Comparison of survival (A) and airway mucus obstruction (B and C) in 6-week-old wild-type (WT),
Il1r12/2, Scnn1b-Tg, and Scnn1b-Tg/Il1r12/2 mice. (A) Frequencies of expected versus obtained
genotypes of mice derived from the intercross of Scnn1b-Tg with Il1r12/2 mice that survived until the
age of 6 weeks. n = 32–154 mice per group from 66 litters. *P, 0.05 for expected versus obtained
genotype frequencies in Scnn1b-Tg compared with WT mice. **P< 0.001 for expected versus
obtained genotype frequencies in Scnn1b-Tg/Il1r12/2 compared with Il1r11/2 mice. †P, 0.05 for
expected versus obtained genotype frequencies in Scnn1b-Tg/Il1r12/2 compared with Scnn1b-Tg
mice. (B) Representative sections of proximal main axial airways stained with alcian blue periodic
acid–Schiff. Scale bar = 100 mm. (C) Airway mucus content determined from the presence of alcian
blue periodic acid–Schiff–positive material in airways from 6-week-old mice. n = 20–28 mice per
group from 23 litters. *P< 0.001 compared with WT mice. †P, 0.01 compared with Scnn1b-Tg
mice.
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pathogenesis was buttressed by recent
studies demonstrating that airway
neutrophilia and mucus obstruction are
already present in infants with CF, mostly
in the absence of detectable bacterial
infection (1, 2). However, these
observational studies in infants with CF did
not permit determination of whether
inflammation occurred before or after the
onset of mucus obstruction, and what
stimuli trigger early inflammation in the
absence of infection.
In previous longitudinal studies in
Scnn1b-Tg mice with CF-like lung disease,
we demonstrated that airway mucus
plugging caused by increased absorption of
Na1 and liquid from airway surfaces was
associated with cellular hypoxia and
necrosis of a subset of airway Clara cells,
as evidenced by in vivo labeling with the
hypoxia probe pimonidazole hydrochloride
and transmission electron microscopy
studies showing intracellular glycogen
depletion, endoplasmic recticulum (ER)
vacuolarization, and pyknotic nuclei as sign
of necrosis (20). Necrotic cells were
observed from the first days of life before
the onset of neutrophilic inflammation,
whereas chronic airway neutrophilia
with elevated levels of the neutrophil
chemoattractant KC, the functional
ortholog of IL-8 in humans, was detected
from postnatal day 5 onward (20, 21).
Interestingly, neutrophilic inflammation
was also observed in Scnn1b-Tg mice raised
in germ-free conditions demonstrating that
inflammation occurred even with greatly
reduced levels of pathogen-associated
molecular patterns that activate MyD88
signaling via TLR (34).
Based on these results, and reports that
activation of MyD88 signaling via IL-1R on
nonhematopoietic cells by IL-1a secreted in
response to necrotic cell death constitutes
a potent stimulus of sterile neutrophilic
inflammation in other organs (12, 13) we
investigated the role of this pathway in the
development of airway neutrophilia in
Scnn1b-Tg mice. We found that genetic
deletion of IL-1R had no effect on elevated
necrotic airway epithelial cells and IL-1a,
but abrogated airway neutrophilia and
reduced KC in 5-day-old neonatal Scnn1b-
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Figure 5. Severity of lung disease is associated with IL-1Ra transcript levels in neonatal Scnn1b-Tg mice. (A–C) Quantification of tracheal mucus
obstruction and microarray gene expression analysis of 3-day-old Scnn1b-Tg and wild-type (WT) mice maintained on a mixed genetic background
(C57BL/6N 3 C3H/HeN). (A) Representative sections of trachea from a 3-day-old WT mouse, a Scnn1b-Tg mouse with mild mucus obstruction, and
a Scnn1b-Tg mouse with severe mucus obstruction stained with alcian blue periodic acid–Schiff. Scale bar = 500 mm. (B) Distribution of severity of
tracheal mucus obstruction as determined from the percentage of the cross-sectional area of the tracheal lumen obstructed with alcian blue periodic
acid–Schiff–positive material in 3-day-old Scnn1b-Tg mice. n = 102 mice from 31 litters. (C) Summary of degenerative epithelial cells per millimeter of the
basement membrane in airways from WT mice and Scnn1b-Tg mice with mild (<20% of luminal area) or severe (>80% of luminal area) mucus
obstruction. n = 6–15 mice per group from 15 litters. *P, 0.01 and **P< 0.001 compared with WT mice. (D) Heat map of genes related to inflammation
that showed significant changes in expression in WT mice compared with Scnn1b-Tg mice with mild (<20% of luminal area) or severe (>80% of luminal
area) mucus obstruction. n = 4 mice per group. (E ) Quantitative real-time reverse transcriptase polymerase chain reaction for Il1ra expression in lungs from
WT mice, Scnn1b-Tg mice with mild mucus obstruction, and Scnn1b-Tg mice with severe mucus obstruction. n = 6–7 mice per group from 10 litters.
*P, 0.01 and **P< 0.001 compared with WT mice. †P, 0.01 compared with severely obstructed Scnn1b-Tg mice.
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released in a fully functional form, IL-1R is
activated by IL-1b that requires caspase-
1–dependent activation of its inactive
precursor in the inflammasome (15). In
addition to neutrophils and KC, IL-1b was
elevated in 5-day-old Scnn1b-Tg mice, but
reduced to near normal levels in Scnn1b-
Tg/Il1r12/2 mice (Figure 1), indicating
that secretion of IL-1b occurred secondary
to IL-1a–mediated activation of IL-
1R–MyD88 signaling and inflammation.
Tissue localization by in situ hybridization
and immunohistochemistry showed
distinct signals for IL-1a transcripts and
protein in the airway epithelium and to
a lesser extent in lung parenchyma, but not
in macrophages contained in lung sections
from WT and Scnn1b-Tg mice (Figure 2;
see Figure E1). As observed in neonatal
mice, necrotic airway epithelial cells
remained elevated, but airway neutrophilia
and KC were significantly reduced in
adult Scnn1b-Tg/Il1r12/2 compared with
Scnn1b-Tg mice (Figure 3). Collectively,
these results identify activation of IL-1R-
MyD88 signaling by IL-1a that is released
from airway epithelial cells undergoing
necrosis, rather than infiltrating macrophages
responding to epithelial injury, as an
important pathway in the onset and
perpetuation of neutrophilic inflammation in
mice with CF-like lung disease.
Our studies also demonstrate that IL-
1R–MyD88 pathway activation by epithelial
necrosis contributes to CF-like airway
mucus obstruction in Scnn1b-Tg mice.
Previous longitudinal studies demonstrated
that a subgroup of Scnn1b-Tg mice die in
the neonatal period because of severe
mucus plugging of the trachea and that
adult survivors exhibit chronic mucus
obstruction of intrapulmonary airways.
Consistent with a role of IL-1R–MyD88
signaling in airway mucus obstruction in
the present study, survival was significantly
increased and airway mucus content was
reduced in adult Scnn1b-Tg/Il1r12/2
compared with Scnn1b-Tg mice (Figure 4).
The importance of IL-1R–MyD88 signaling
in early mucus obstruction was supported
by independent studies using whole-
genome expression profiling of lungs from
neonatal Scnn1b-Tg mice on a mixed
genetic background with variable mucus
obstruction (20) that identified an inverse
relationship between the severity of tracheal
mucus plugging and expression of Il1ra
(Figure 5). Of note, previous studies from
various laboratories showed that activation
of MAPK and nuclear factor-kB via TLR-
MyD88 signaling induces mucin expression
in mice and human airway cultures (35–37)
establishing a role of this pathway in mucus
hypersecretion associated with airway
infection and inflammation. Furthermore,
it was shown that genetic deletion of the
adaptor molecule MyD88 reduced goblet
cell metaplasia and airway mucus plugging
in neonatal Scnn1b-Tg mice in the context
of bacterial airway infection. However,
whether MyD88 was activated via TLRs or
IL-1R remained unknown (34).
We recently demonstrated that lack
of NE, another potent stimulus of mucus
hypersecretion (10), reduced goblet cell
metaplasia and reduced elevated mucin
expression. However, in contrast to genetic
deletion of Il1r, lack of NE was not
sufficient to prevent airway mucus
obstruction and associated mortality in
Scnn1b-Tg mice (9). Based on these results,
we speculate that activation of the IL-
1R–MyD88 pathway by IL-1a released
from necrotic epithelial cells provides
an alternative stimulus of mucin
hypersecretion that may aggravate mucus
hyperconcentration and plugging
independent of pathogens and NE. In
addition, these results suggest that the
endogenous inhibitor of this pathway, IL-
1Ra, may act not only as a modulator of
inflammation, but also as a potential
modifier of mucus hypersecretion and
obstruction. However, in contrast to
previous studies where preventive
treatment with the epithelial sodium
channel blocker amiloride abrogated airway
mucus obstruction almost completely















































Figure 6. Lack of IL-1R reduces emphysema in Scnn1b-Tg mice. Comparison of distal airspace
morphology (A) and mean linear intercepts and destructive index (B) in 6-week-old wild-type (WT),
Il1r12/2, Scnn1b-Tg, and Scnn1b-Tg/Il1r12/2 mice. (A) Representative lung sections stained with
hematoxylin and eosin. Scale bars = 100 mm. (B, left) Summary of mean linear intercepts. n = 17–19
mice per group from 27 litters. *P< 0.001 compared with WT mice. †P, 0.05 compared with
Scnn1b-Tg mice. (B, right) Destructive index. n = 6 mice per group from 13 litters. *P< 0.001
compared with WT mice. †P< 0.001 compared with Scnn1b-Tg mice.
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(z50%) (22), neither genetic deletion nor
pharmacologic inhibition of IL-1R signaling
had effects on epithelial necrosis in Scnn1b-
Tg mice (Figures 1, 3, 7). We therefore
speculate that the moderate (z40%)
reduction in airway mucus content
obtained by inhibition of IL-1R signaling
was not sufficient to improve luminal O2
delivery to levels that result in a measurable
reduction of epithelial necrosis in the
presence of CF-like Na1 hyperabsorption
that has been reported to increase epithelial
O2 consumption (16, 20).
Neutrophilic airway inflammation
constitutes a major risk factor for early onset
and progression of bronchiectasis in
patients with CF and is associated with early
structural damage of distal airspaces in
Scnn1b-Tg mice (1, 4, 20, 30). The present
study demonstrates that genetic deletion of
the IL-1R–MyD88 pathway resulted in
a significant reduction of structural lung
damage in this model of CF lung disease
(Figure 6). In recent studies, we
demonstrated that proteolytic activities
of NE and matrix metalloproteinase
12 released from activated neutrophils and
macrophages in chronic airway
inflammation play key roles in emphysema
formation in Scnn1b-Tg mice (9, 27). We
therefore speculate that the abrogation of
airway neutrophilia reduced elastolytic
activity, thus ameliorating structural lung
damage in Scnn1b-Tg/Il1r12/2 mice
(Figure 6). However, infiltration of
airspaces by enlarged, morphologically
activated macrophages persisted
(Figure 1C) suggesting that secretion of
matrix metalloproteinase 12 may contribute
to residual lung damage observed in
Scnn1b-Tg/Il1r12/2mice (Figure 6).
Hypoxia is a common feature in CF
lungs that is caused by airway mucus
plugging and increased epithelial oxygen
consumption due to increased epithelial
sodium channel–mediated absorption of
Na1 and fluid from airway surfaces (16,
17). The role of hypoxia in CF has been
studied in the context of chronic infection
with Pseudomonas aeruginosa and
anaerobic bacteria (17, 38). However,
although it is well established that hypoxic
necrosis is a potent stimulus of neutrophilic
inflammation in other common diseases,
such as stroke and myocardial infarction
(12), the prevalence of necrotic cells in CF
airways remains unknown. To determine
the relevance of our findings in Scnn1b-Tg
mice for CF lung disease in humans, we
evaluated sections of small airways from
patients with CF for the presence of
necrotic cells. We show for the first time
that hydropic degeneration (i.e., the
morphologic correlate of necrotic cell death
[39]), was detectable in the airway
epithelium and significantly increased
(z2.3-fold) in patients with CF compared
with control subjects (Figure 8).
Based on recent evidence suggesting
that patients with COPD exhibit acquired
CF transmembrane conductance regulator
(CFTR) dysfunction leading to CF-like
dehydration of airway surfaces (40–43) and
that small airways mucus plugging also
plays an important role in COPD (44), we
extended our studies to patients with this
common chronic obstructive lung disease.
Similar to CF, small airways from patients
with COPD exhibited intraluminal mucus
obstruction and increased numbers of highly






























































































































Figure 7. Anakinra treatment reduces neutrophilic airway inflammation and emphysema in Scnn1b-Tg mice. Adult (4–6 wk old) wild-type (WT) and
Scnn1b-Tg mice were treated with subcutaneous injection of anakinra (200 mg/kg body weight) or vehicle (NaCl 0.9%) alone twice per day for 7 days.
Comparison of airway epithelial necrosis (A), bronchoalveolar lavage (BAL) inflammatory cell counts (B), and keratinocyte chemoattractant (KC) levels
(C). (A) Summary of degenerative epithelial cells per millimeter of basement membrane. n = 6–9 mice per group. (B) Inflammatory cell counts and (C)
concentrations of KC in BAL. n = 11–16 mice per group. (D and E) Comparison of mean linear intercepts (D) and destructive index (E). n = 6–9 mice per
group. (F) Airway mucus content determined from the presence of alcian blue periodic acid–Schiff–positive material in airways. n = 14–16 mice per group.
*P, 0.05, **P, 0.01, and ***P< 0.001 compared with vehicle-treated WT mice. †P, 0.05 and ‡P, 0.01 compared with vehicle-treated Scnn1b-Tg mice.
Data were derived from four independent studies with mice from 14 litters. Eos. = eosinophils; Lymph. = lymphocytes; Mac. = macrophages; PMN = neutrophils.
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Furthermore, we found that necrotic cell
densities correlated with airway mucus
content in CF and COPD (Figure 8). Taken
together, these results show that small
airways of patients with CF and COPD
exhibit increased frequencies of necrotic
epithelial cells in situ suggesting that release
of IL-1a from necrotic cells may activate
IL-1R–MyD88 signaling and contribute
to neutrophilic airway inflammation
characteristic of these chronic obstructive
lung diseases.
Our preclinical studies with the IL-1Ra
anakinra show that pharmacologic
inhibition of IL-1R signaling had significant
protective effects in adult Scnn1b-Tg mice
with chronic lung disease (Figure 7; see
Figure E2). Similar to genetic deletion of IL-
1R, anakinra treatment abrogated airway
neutrophilia almost completely and
reduced KC levels significantly in
Scnn1b-Tg mice demonstrating potent
antiinflammatory effects. Of note,
inhibition of airway neutrophilia by
anakinra treatment was associated with
a significant reduction of distal airspace
enlargement and structural damage
characteristic of Scnn1b-Tg mice (20).
These results are consistent with an
important role of NE in emphysema
formation in Scnn1b-Tg mice (9), and work
from other laboratories demonstrating
substantial neoalveolarization during
compensatory lung growth after
pneumonectomy or elastase-induced
emphysema in mice (45, 46).
Taken together, these results support
inhibition of IL-1R signaling as a promising
antiinflammatory strategy. However,
therapeutic strategies that inhibit
neutrophilic inflammation to prevent lung
damage also have the potential risk to
further compromise antibacterial host
defense and aggravate infection-related
exacerbations in CF (47). Because TLR-
MyD88 signaling remains intact even when
the IL-1R–MyD88 pathway is blocked,
therapeutic targeting of IL-1R may provide
an attractive strategy to reduce CF airways
inflammation without disabling host
defense against pathogens. Consistent with
this concept, previous studies showed that
recruitment of neutrophils by microbial
stimuli was not impaired in Il1r12/2 mice
and patients treated with IL-1 blocking
agents for other inflammatory disorders
have not shown an increased risk of
opportunistic infections (12, 15). Although
genetic deletion and pharmacologic
inhibition of IL-1R reduced influx
of neutrophils, recruitment of and
morphologic activation of macrophages
remained intact in Scnn1b-Tg mice
(Figure 1C) and in mice with necrosis-
induced inflammation in other organs (12).
We therefore speculate that therapeutic
inhibition of IL-1R signaling may have
benefits by limiting the damaging effects of
airway neutrophils (Figure 7) (4, 8, 9, 31)
without compromising antibacterial host
defense or macrophage-mediated tissue
repair functions in CF airways. In addition
to anakinra, several other agents that block
IL-1 signaling including soluble decoy
receptor and IL-1b neutralizing antibodies
have been approved for the treatment of
other chronic inflammatory diseases (15),
and these existing drugs may facilitate
clinical testing of benefits of IL-1R pathway
blockade in CF and potentially other
chronic neutrophilic airway diseases.
In addition to the Scnn1b-Tg mouse,
CFTR-deficient pigs and ferrets have
recently become available for in vivo studies
of the relationship between mucus,
inflammation, and infection in early CF
lung disease (48, 49). In newborn CF pigs,
lack of CFTR was shown to cause impaired
mucociliary clearance and a pH-dependent
defect in bacterial killing in the absence of
detectable airway surface liquid depletion
and inflammation (48, 50, 51). In newborn















































































Figure 8. Mucus obstruction is associated with epithelial necrosis in small airways of patients with
cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). (A) Representative airway
sections from a control subject and patients with CF and COPD stained with alcian blue periodic
acid–Schiff to determine the presence of mucus (top, scale bars = 100 mm) and hematoxylin and
eosin to identify degenerative airway epithelial cells (arrows) (bottom, scale bars = 10 mm). (B and C)
Comparison of airway mucus content determined from the presence of alcian blue periodic
acid–Schiff–positive material (B) and numeric densities of degenerative airway epithelial cells in
control, CF, and COPD groups (C). n = 8–19 individuals per group. *P, 0.01 and **P, 0.001
compared with control subjects. (D) Correlation between numeric densities of degenerative cells and
airway mucus content in control subjects and patients with CF and COPD. n = 8–15 individuals per
group. Pearson product-moment correlation coefficient r = 0.53, P, 0.01.
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to produce airway surface liquid depletion
and elevated IL-8 levels in BAL even in the
absence of detectable bacteria. CF ferrets
also showed a defect in bacterial killing
following challenge with P. aeruginosa.
However, this defect was not pH-dependent
(52). Despite these distinct differences in
initial phenotypes, both models develop
a spontaneous lung disease that shares key
features of lung disease in infants and
young children with CF (1, 2, 53). These
include regions with highly tenacious
mucus plugs that contain neutrophils and
cause obstruction of airways and air
trapping in otherwise unaffected lungs,
and regions with a more purulent airway
exudate and associated pneumonia (48, 49).
We expect that these additional animal
models will provide unique opportunities
for further elucidation of the relative role of
epithelial necrosis and IL-1R signaling
in the complex in vivo pathogenesis of
neutrophilic inflammation at different
stages of CF lung disease.
In summary, this study demonstrates
for the first time that necrosis of airway
epithelial cells is a characteristic feature of
CF lung disease in mice and patients that
provides a potent stimulus of neutrophilic
inflammation. Furthermore, we identified
activation of IL-1R–MyD88 signaling by
IL-1a released from necrotic cells as the
mechanism underlying necrosis-induced
airway neutrophilia. Besides neutrophilic
inflammation, we show that activation of
the IL-1R–MyD88 pathway is implicated in
mucus obstruction and structural lung
damage in vivo. These results suggest that
hypoxic epithelial necrosis may provide an
important trigger for neutrophilic airway
inflammation independent of bacterial
infection, and support inhibition of IL-1R
signaling as a novel antiinflammatory
strategy in CF and potentially other
mucoobstructive airway diseases. n
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